PTA Balloon Catheter Market Growth, Size, Trends ,Analysis & Forecast to 2034

Global PTA Balloon Catheter Market Growth, Size, Trends Analysis- By Material Type, By Application, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Published: Jul-2025 Report ID: HLCA25210 Pages: 1 - 255 Formats*:     
Category : Healthcare
PTA Balloon Catheter Market Introduction and Overview 

According to SPER Market Research, the Global PTA Balloon Catheter Market is estimated to reach USD 6428.37 million by 2034 with a CAGR of 8.56%.

The report includes an in-depth analysis of the Global PTA Balloon Catheter Market, including market size and trends, product mix, Applications, and supplier analysis. The market is experiencing growth due to the rising elderly population, increasing cases of cardiovascular diseases, and a shift toward minimally invasive surgical procedures. Conditions like peripheral artery disease, often linked to aging, diabetes, and high blood pressure, are becoming more common, increasing the demand for treatment options. Minimally invasive surgeries are preferred for their lower cost, quicker recovery, and reduced risk. PTA balloon catheters remain widely used due to their efficiency and lack of substitutes. Technological advancements and ongoing research efforts by companies are also contributing to market expansion.
By Material Type:
The nylon segment leads the market due to its stretchability and adaptability, making it ideal for medical applications. Its ability to significantly expand when inflated helps the balloon conform to the vessel’s shape, especially useful in bridging lesions. Nylon’s thicker wall structure also provides a broader profile, enhancing contact with vessel walls for improved treatment. Meanwhile, polyurethane balloons are gaining traction for their excellent biocompatibility and biodegradability. These qualities make them safe for long-term use in the body, reducing the risk of adverse reactions and supporting their growing popularity in medical procedures.

By Application:
The peripheral artery disease segment dominates the market, largely driven by the rising incidence of the condition. PAD is closely linked to atherosclerosis, which shares common risk factors with coronary artery disease, such as smoking, diabetes, and high blood pressure. As a result, effective diagnosis and management of atherosclerosis are essential in treating PAD, making percutaneous transluminal angioplasty (PTA) balloons vital tools in its treatment. Additionally, the growing adoption of drug-eluting balloons, which deliver medication directly to affected areas, has enhanced treatment effectiveness and increased the reliance on PTA balloons, further boosting their demand in managing peripheral artery disease.

By End User:
Hospitals hold a dominant position in the market due to the growing prevalence of cardiovascular diseases and the increasing number of diagnostic visits and cardiac procedures. Their access to advanced equipment, skilled surgeons, and comprehensive care services attracts a high volume of patients. Meanwhile, ambulatory surgical centers are gaining momentum due to challenges in scheduling hospital appointments, higher costs, and extended stays. These centers offer more affordable care, quicker recovery times, and easier scheduling, making them an increasingly popular choice for patients.

Regional Insights:
North America leads the PTA balloon catheter market due to supportive reimbursement policies, technological advancements, and the presence of major manufacturers. A notable example is the recent launch of an innovative injectable balloon catheter by Summa Therapeutics, marking progress in treating below-the-knee peripheral artery disease. Europe follows closely, supported by a strong healthcare infrastructure and a growing trend toward outpatient care. The region's market is further bolstered by the presence of numerous medical equipment companies offering catheter-based solutions.



Market Competitive Landscape:
The global PTA Balloon Catheter Market is highly consolidated. Some of the market key players are Medtronic, Tuermo Corporation, Cardinal Health, Boston Scientific Corporation, Natec Medical, Cook Medical, Biotronik, Surmodics, Inc., Andratec.

Recent Developments:
In January 2024, Cook Medical announced the availability of its Slip-Cath Beacon Tip hydrophilic selective catheter for use in both the United States and Canada.
In March 2023, BrosMed announced that its Tiche 0.035 High-Pressure PTA Balloon Dilatation Catheter received CE MDR approval. The device is specifically designed to treat heavily calcified peripheral vascular disease and complex arteriovenous cases, in compliance with the European Medical Device Regulation.

Scope of the report:
 Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
 Forecast period 2025-2034
Segments covered By Material Type, By Application, By End Use
Regions covered
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa
Companies Covered
Medtronic, Tuermo Corporation, Cardinal Health, Boston Scientific Corporation, Natec Medical, Cook Medical, Biotronik, Surmodics, Inc., Andratec.

Key Topics Covered in the Report
  • Global PTA Balloon Catheter Market Size (FY’2021-FY’2034)
  • Overview of Global PTA Balloon Catheter Market
  • Segmentation of Global PTA Balloon Catheter Market By Material Type (Polyurethane, Nylon, Others)
  • Segmentation of Global PTA Balloon Catheter Market By Application (Peripheral, Artery Disease, Coronary Artery Disease )
  • Segmentation of Global PTA Balloon Catheter Market By End Users (Hospital, Ambulatory Surgical Centers, Others)
  • Statistical Snap of Global PTA Balloon Catheter Market
  • Expansion Analysis of Global PTA Balloon Catheter Market
  • Problems and Obstacles in Global PTA Balloon Catheter Market
  • Competitive Landscape in the Global PTA Balloon Catheter Market
  • Details on Current Investment in Global PTA Balloon Catheter Market
  • Competitive Analysis of Global PTA Balloon Catheter Market
  • Prominent Players in the Global PTA Balloon Catheter Market
  • SWOT Analysis of Global PTA Balloon Catheter Market
  • Global PTA Balloon Catheter Market Future Outlook and Projections (FY’2025-FY’2034)
  • Recommendations from Analyst
1.Introduction
1.1.Scope of the report
1.2.Market segment analysis 

2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data
2.1.2.Primary Data
2.1.3.SPERs internal database
2.1.4.Premium insight from KOLs
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation

3.Executive Summary

4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers
4.1.2.Restraints
4.1.3.Opportunities
4.1.4.Challenges

5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths
5.1.2.Weaknesses
5.1.3.Opportunities
5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape
5.2.2.Economic Landscape
5.2.3.Social Landscape
5.2.4.Technological Landscape
5.2.5.Environmental Landscape
5.2.6.Legal Landscape
5.3.PORTERs Five Forces 
5.3.1.Bargaining power of suppliers
5.3.2.Bargaining power of buyers
5.3.3.Threat of Substitute
5.3.4.Threat of new entrant
5.3.5.Competitive rivalry
5.4.Heat Map Analysis

6.Competitive Landscape
6.1.Global PTA Balloon Catheter Market Manufacturing Base Distribution, Sales Area, Product Type 
6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global PTA Balloon Catheter Market

7.Global PTA Balloon Catheter Market, By Material Type, (USD Million) 2021-2034 
7.1.Polyurethane
7.2.Nylon
7.3.Others

8.Global PTA Balloon Catheter Market, By Application, (USD Million) 2021-2034 
8.1.Peripheral Artery Disease
8.2.Coronary Artery Disease 

9.Global PTA Balloon Catheter Market, By End Users, (USD Million) 2021-2034 

9.1.Hospital
9.2.Ambulatory Surgical Centers
9.3.Others

10.Global PTA Balloon Catheter Market, (USD Million) 2021-2034 
10.1.Global PTA Balloon Catheter Market Size and Market Share

11.Global PTA Balloon Catheter Market, By Region, 2021-2034 (USD Million)
11.1.Asia-Pacific
11.1.1.Australia
11.1.2.China
11.1.3.India
11.1.4.Japan
11.1.5.South Korea
11.1.6.Rest of Asia-Pacific
11.2.Europe
11.2.1.France
11.2.2.Germany
11.2.3.Italy
11.2.4.Spain
11.2.5.United Kingdom
11.2.6.Rest of Europe
11.3.Middle East and Africa
11.3.1.Kingdom of Saudi Arabia 
11.3.2.United Arab Emirates
11.3.3.Qatar
11.3.4.South Africa
11.3.5.Egypt
11.3.6.Morocco
11.3.7.Nigeria
11.3.8.Rest of Middle-East and Africa
11.4.North America
11.4.1.Canada
11.4.2.Mexico
11.4.3.United States
11.5.Latin America
11.5.1.Argentina
11.5.2.Brazil
11.5.3.Rest of Latin America 

12.Company Profile
12.1.Medtronic
12.1.1.Company details
12.1.2.Financial outlook
12.1.3.Product summary 
12.1.4.Recent developments
12.2.Tuermo Corporation
12.2.1.Company details
12.2.2.Financial outlook
12.2.3.Product summary 
12.2.4.Recent developments
12.3.Cardinal Health
12.3.1.Company details
12.3.2.Financial outlook
12.3.3.Product summary 
12.3.4.Recent developments
12.4.Boston Scientific Corporation.
12.4.1.Company details
12.4.2.Financial outlook
12.4.3.Product summary 
12.4.4.Recent developments
12.5.Natec Medical
12.5.1.Company details
12.5.2.Financial outlook
12.5.3.Product summary 
12.5.4.Recent developments
12.6.Cook Medical
12.6.1.Company details
12.6.2.Financial outlook
12.6.3.Product summary 
12.6.4.Recent developments
12.7.Biotronik
12.7.1.Company details
12.7.2.Financial outlook
12.7.3.Product summary 
12.7.4.Recent developments
12.8.Surmodics, Inc.
12.8.1.Company details
12.8.2.Financial outlook
12.8.3.Product summary 
12.8.4.Recent developments
12.9.Andratec
12.9.1.Company details
12.9.2.Financial outlook
12.9.3.Product summary 
12.9.4.Recent developments
12.10.Others

13.Conclusion

14.List of Abbreviations

15.Reference Links

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3


Frequently Asked Questions About This Report
PTA Balloon Catheter Market projected to reach USD 6428.37 by 2034, growing at a CAGR of 8.56 % during the forecast period.
PTA Balloon Catheter Market from 2025. The Market is expected to reach USD 6428.37 by 2034, at a CAGR of 8.56% during the forecast period.
PTA Balloon Catheter Market CAGR of 8.56% during the forecast period.
You can get the sample pages by clicking the link - Click Here
PTA Balloon Catheter Market size is USD 6428.37 from 2025 to 2034.
"PTA Balloon Catheter Market covered By Material Type, By Application, By End Use"
The North America is anticipated to have the highest Market share in the PTA Balloon Catheter Market .
" Medtronic, Tuermo Corporation, Cardinal Health, Boston Scientific Corporation, Natec Medical, Cook Medical, Biotronik, Surmodics, Inc., Andratec. "
The report includes an in-depth analysis of the Global PTA Balloon Catheter Market, including market size and trends, product mix, Applications, and supplier analysis
PLACE AN ORDER
  • 15 % off
     
    $ 4250
  • 20 % off
             
    $ 5650
  • 25 % off
         
    $ 7450
Pre-Purchase Inquiry
SEND AN INQUIRY
NEED CUSTOMIZATION?
Request Customization
CALL OR EMAIL US
US:
India:
Email:
100% Secure Payment

SPER American Express
SPER VISA
SPER Master Card
SPER Mestro
SPER Paypal
SPER CCAvenues

Have a glance of the Report

  Download Free Sample

Looking for Customization?

 Customization Request

Have a Question?

 Reach Our Analysis Team

COVID-19 impact analysis?

 Request Analysis

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.

SPER-Astellas Pharma
SPER-Microsoft
SPER-EY
SPER-McKinsey
SPER-Bain
SPER-Max-Healthcare
SPER-DHL
SPER-IQVIA
SPER-Mitsubishi Logistics
SPER-PACCOR
SPER-Macmillan Education
SPER-Kankar IMRB
SPER-ITA
SPER-PWC
SPER-SAPTCA
SPER-Straumann
SPER-MENARINI Silicon Biosystems
SPER-IPSOS
SPER-Heineken